According to the earnings results announced by Japan Hospice Holdings after the market close on 14 August, ordinary profit for the cumulative second quarter of the fiscal year ending December 2026 was ¥290 million, up 38.4% year on year. The company withdrew its full-year forecast and changed it to undecided, and also changed its year-end dividend to undecided.
Japan Hospice Holdings announced its earnings results after the market close on 14 August, reporting that consolidated ordinary profit for the cumulative second quarter of the fiscal year ending December 2026 (January–June) increased 38.4% year on year to ¥290 million.
For the latest 3-month period, consolidated ordinary profit for April–June was ¥140 million, up 35.5% year on year, while the operating profit margin on sales improved from 6.4% in the same period of the previous year to 7.3%.
At the same time, the company withdrew its previous full-year earnings forecast, which called for consolidated ordinary profit of ¥1 billion, and changed it to undecided. The year-end dividend paid in a single payment was also changed from the previous forecast of ¥25 to undecided.
The article was prepared based on numerical data disclosed by the company, and readers are advised to make their own investment decisions after verifying the information.